Recipharm is investing €2.6 million in additional manufacturing capacity to support increased demand at its sterile manufacturing facility in Kaysersberg, France. The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops. Part of the company’s phased expansion plan for the facility, this investment will add additional capacity and capabilities for the company’s customers, as well as future business. Yves Buelens, General Manage...